Quality of life and paracetamol in advanced dementia (Q-PID): protocol of a randomised double-blind placebo-controlled crossover trial

被引：0

作者：

Paulien H. van Dam

Wilco P. Achterberg

Jacobijn Gussekloo

Bettina S. Husebo

Monique A. A. Caljouw

机构：

[1] Leiden University Medical Center,Department of Public Health and Primary Care

[2] Leiden University Medical Center,Section of Gerontology and Geriatrics, Department of Internal Medicine

[3] University of Bergen,Department of Global Public Health and Primary Care, Centre for Elderly – and Nursing Home Medicine

[4] Municipality of Bergen,undefined

来源：

BMC Geriatrics | / 18卷

关键词：

Quality of life; Paracetamol; Dementia; Nursing home; QUALIDEM;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[1] Quality of life and paracetamol in advanced dementia (Q-PID): protocol of a randomised double-blind placebo-controlled crossover trial
van Dam, Paulien H.
Achterberg, Wilco P.
Gussekloo, Jacobijn
Husebo, Bettina S.
Caljouw, Monique A. A.
[J]. BMC GERIATRICS, 2018, 18
[2] Does paracetamol improve quality of life, discomfort, pain and neuropsychiatric symptoms in persons with advanced dementia living in long-term care facilities? A randomised double-blind placebo-controlled crossover (Q-PID) trial
van Dam, Paulien H.
Achterberg, Wilco P.
Husebo, Bettina S.
Caljouw, Monique A. A.
[J]. BMC MEDICINE, 2020, 18 (01)
[3] Does paracetamol improve quality of life, discomfort, pain and neuropsychiatric symptoms in persons with advanced dementia living in long-term care facilities? A randomised double-blind placebo-controlled crossover (Q-PID) trial
Paulien H. van Dam
Wilco P. Achterberg
Bettina S. Husebo
Monique A. A. Caljouw
[J]. BMC Medicine, 18
[4] A DOUBLE-BLIND, PLACEBO-CONTROLLED, CROSSOVER TRIAL WITH NICERGOLINE IN PATIENTS WITH SENILE DEMENTIA
ARRIGO, A
MOGLIA, A
BORSOTTI, L
MASSARINI, M
ALFONSI, E
BATTAGLIA, A
SACCHETTI, G
[J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY RESEARCH, 1982, 2 (04) : 33 - 41
[5] CANNABINOL (CBN) EFFECTS IN INSOMNIA DISORDER: A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, CROSSOVER, CLINICAL TRIAL PROTOCOL
Lavender, Isobel
McGregor, Iain
Sureav, Anastasia
McCartney, Danielle
Irwin, Chris
Marshall, Nathaniel
Gordon, Chris
D'Rozario, Angela
Saini, Bandana
Grunstein, Ron
Yee, Brendon
Hoyos, Camilla
[J]. SLEEP, 2023, 46
[6] Gabapentin for Parkinsonism: A double-blind, placebo-controlled, crossover trial
Olson, WL
Gruenthal, M
Mueller, ME
Olson, WH
[J]. AMERICAN JOURNAL OF MEDICINE, 1997, 102 (01): : 60 - 66
[7] Effects of tanshinone on hyperandrogenism and the quality of life in women with polycystic ovary syndrome: protocol of a double-blind, placebo-controlled, randomised trial
Shen, Wenjuan
Zhang, Yuehui
Li, Wei
Cong, Jing
Zhou, Ying
Ng, Ernest H. Y.
Wu, Xiaoke
[J]. BMJ OPEN, 2013, 3 (10):
[8] A Randomised, Double-Blind, Placebo-Controlled Crossover Trial of Resveratrol Supplementation for Prophylaxis of Hormonal Migraine
Dzator, Jemima S. A.
Howe, Peter R. C.
Coupland, Kirsten G.
Wong, Rachel H. X.
[J]. NUTRIENTS, 2022, 14 (09)
[9] The effect of methylphenidate on neurofibromatosis type 1: a randomised, double-blind, placebo-controlled, crossover trial
Laurence Lion-François
François Gueyffier
Catherine Mercier
Daniel Gérard
Vania Herbillon
Isabelle Kemlin
Diana Rodriguez
Tiphanie Ginhoux
Emeline Peyric
Virginie Coutinho
Valentine Bréant
Vincent des Portes
Stéphane Pinson
Patrick Combemale
Behrouz Kassaï
[J]. Orphanet Journal of Rare Diseases, 9
[10] The effect of methylphenidate on neurofibromatosis type 1: a randomised, double-blind, placebo-controlled, crossover trial
Lion-Francois, Laurence
Gueyffier, Francois
Mercier, Catherine
Gerard, Daniel
Herbillon, Vania
Kemlin, Isabelle
Rodriguez, Diana
Ginhoux, Tiphanie
Peyric, Emeline
Coutinho, Virginie
Breant, Valentine
des Portes, Vincent
Pinson, Stephane
Combemale, Patrick
Kassai, Behrouz
[J]. ORPHANET JOURNAL OF RARE DISEASES, 2014, 9 : 142

← 1 2 3 4 5 →